Needle Protection Systems Global Market Report 2026

The needle protection systems market size has grown strongly in recent years. It will grow from $3.48 billion in 2025 to $3.72 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to rising incidence of needlestick injuries, implementation of occupational safety regulations, growth in hospital and outpatient procedures, increasing awareness of bloodborne pathogen risks, expansion of vaccination and injectable drug programs.

The needle protection systems market size is expected to see strong growth in the next few years. It will grow to $4.89 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to growing demand for home care self-injection devices, increasing adoption of automated retractable mechanisms, rising focus on healthcare worker safety compliance, expansion of infection prevention protocols, increasing investment in smart safety monitoring solutions. Major trends in the forecast period include increasing adoption of auto-disable and retractable safety syringes, rising demand for needleless connectors in iv therapy, growing integration of closed medication transfer systems, expansion of prefilled safety syringe utilization, rising emphasis on infection control and sharps injury prevention programs.

The rising prevalence and ongoing risk of bloodborne infectious diseases are expected to boost the growth of the needle protection systems market going forward. Bloodborne infectious diseases are illnesses transmitted through contact with infected blood or certain bodily fluids, including HIV, hepatitis B, and hepatitis C. The continuous occurrence of these infections is driven by factors such as unsafe injection practices, occupational exposure among healthcare workers, and gaps in preventive measures, allowing new infections to persist annually. Needle protection systems are critical in mitigating the risk of bloodborne pathogen transmission by enabling safer handling, use, and disposal of needles and sharps, thereby minimizing accidental needlestick injuries and occupational exposure to infected blood. For example, in April 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, acute hepatitis B cases in the United States totaled 2,214 in 2023, with the estimated true number of infections reaching approximately 14,400 after accounting for under-ascertainment. Therefore, the rising prevalence of bloodborne infectious diseases is driving the growth of the needle protection systems market.

Key companies operating in the needle protection systems market are focusing on leveraging innovative technologies such as, passive safety technology to enhance user safety and prevent needle-stick injuries. Passive safety technology is a mechanism that automatically shields or retracts the needle after use, helping prevent accidental needle-stick injuries, reducing the risk of blood-borne infections, improving overall safety for healthcare workers, and ensuring compliance with modern safety standards in medical settings. For example, in January 2026, Terumo Medical Corporation, a US-based medical device manufacturing company, launched the SurTract Safety Syringe, powered by Roncadelle Operations S.r.l.’s SafeR passive safety technology. The syringe combines a customizable needle selection, a blunt needle design to prevent dulling, and low dead-space construction to minimize medication waste. Additionally, it incorporates ergonomic design features to enhance user comfort and reduce hand fatigue during repetitive injections. SurTract preserves standard injection technique while offering enhanced reliability, intuitive use, and reduced environmental impact, making it suitable for hospitals, clinics, emergency-care settings, and immunization campaigns. Integrating advanced safety technology with practical usability allows these solutions to help healthcare institutions meet stringent occupational safety standards and improve overall patient care outcomes.

In August 2024, MTD Products S.p.A., an Italy-based healthcare technology company, acquired Ypsomed AG’s Pen Needles and Blood Glucose Monitoring Systems for an undisclosed sum. This acquisition enables MTD Products S.p.A. to reinforce its global leadership in diabetes care, expand manufacturing capacity, accelerate innovation in insulin delivery and glucose monitoring technologies, and access high-growth markets such as China and India to better serve the rapidly growing diabetic population worldwide. Ypsomed AG is a Switzerland-based healthcare technology company that specializes in needle protection and safety systems.

Major companies operating in the needle protection systems market are Cardinal Health Inc., Medtronic plc, Becton Dickinson Company, Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Smiths Group plc, West Pharmaceutical Services Inc., ICU Medical Inc., Gerresheimer AG, Merit Medical Systems Inc., Vygon S.A., Codan Ltd, SOL-Millennium Medical Group Inc., Retractable Technologies Inc., HMD Healthcare Ltd., Revolution Medical Corporation, Lifelong Meditech Ltd., DMC Medical Ltd.

North America was the largest region in the needle protection systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle protection systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the needle protection systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The needle protection systems market consists of sales of safety needles, retractable syringes, needle shields, passive safety devices, active safety devices, and needle protection accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Needle protection systems are safety devices designed to prevent accidental needle sticks and lower the risk of injury during medical procedures. They typically feature retractable needles, protective shields, or locking mechanisms that cover the needle immediately after use, enhancing safety by reducing exposure to bloodborne pathogens and other contaminants.

The key device types of needle protection systems include safety syringes, safety intravenous (IV) catheters and blood collection sets, needleless connectors and closed IV systems, sharps containers and disposal systems, and training, compliance, and monitoring services. Safety syringes are devices designed to prevent needlestick injuries and ensure safe injection practices. Mechanisms include manual retractable, automated retractable, and hinged or sliding shields, with distribution through direct tender, retail pharmacies, and online pharmacies. Clinical applications include medication administration, phlebotomy and blood collection, intravenous therapy and vascular access, surgical procedures, and home care self-injection, serving end users such as hospitals, ambulatory and outpatient clinics, home healthcare providers, blood banks and laboratories, and diagnostic centers.

Tariffs on imported medical-grade steel, polymers, and injection device components are impacting the needle protection systems market by increasing manufacturing and procurement costs, particularly affecting safety syringes and safety intravenous catheter segments. Regions such as North America and Europe that rely on global medical device supply chains are most affected, especially hospitals and outpatient clinics. Higher input costs may influence pricing and procurement cycles; however, tariffs are also encouraging localized medical device production, strengthening domestic manufacturing capacity, and promoting innovation in cost-efficient safety mechanisms.

The needle protection systems market research report is one of a series of new reports that provides needle protection systems market statistics, including needle protection systems industry global market size, regional shares, competitors with a needle protection systems market share, detailed needle protection systems market segments, market trends and opportunities, and any further data you may need to thrive in the needle protection systems industry. This needle protection systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.